Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 


NZ research shows drug companies misleading the public

MEDIA RELEASE              December 18, 2013

The December edition of the scientific journal Acta Psychiatrica Scandinavica has published a review of studies examining the role of drug companies in the funding of mental health websites, including the first meta-analysis of studies (all conducted at the University of Auckland) comparing sites funded and not funded by drug companies.

The review identified studies of websites for six problems: Depression, Post Traumatic Stress Disorder, Anorexia, Attention Deficit Hyperactivity Disorder, Schizophrenia and Erectile Dysfunction. 152 (42%) of the 365 websites were drug company funded (including 22 actually owned by companies); with the most heavily industry-funded websites being for schizophrenia (58%).

The meta-analysis found that company funded sites are significantly biased toward biogenetic causal explanations (eg ‘chemical imbalance’ and ‘genetics’) (p < 0.01) and toward medication (p < 0.0001) compared to sites that are financially independent of the industry. For example, in 48% of the industry sponsored Erectile Dysfunction websites medication was theonly treatment mentioned, compared to 10% of websites not funded by drug companies.

Furthermore, industry funded websites for Schizophrenia were significantly more likely to perpetuate the stigmatising myths that patients become violent if they come off medication and that people with this diagnosis have little chance of recovery – by using terms such as devastating, disabling, severe, debilitating, chronic, degenerative, and long-term.

The authors, Professor John Read (ex University of Auckland, now University of Liverpool) and Amanda Cain (University of Auckland, New Zealand), concluded that “Drug company–funded websites cannot be considered an objective source of mental health information, for the public or practitioners” and that “The pervasive international influence of the pharmaceutical industry in all aspects of mental health policy, practice and research now clearly extends to the internet”.

The paper adds: “Practitioners are encouraged to inform patients about the bias inherent in industry-sponsored websites and to recommend, instead, more balanced websites that present a range of evidence-based information about causes and treatments”.
and….

“The pharmaceutical industry is using its enormous financial power to promote its products, and a
somewhat simplistic ideology about causation that provides the rationale for those products, by funding the websites of other organizations, including cash-strapped NGOs. The internet is extraordinarily hard to regulate, but very easy to influence if you have the motive and money to do so.”

ENDS

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Media: Julian Wilcox Leaves Māori TV

Māori Television has confirmed the resignation of Head of News and Production Julian Wilcox. Mr Maxwell acknowledged Mr Wilcox’s significant contribution to Māori Television since joining the organisation in 2004. More>>

ALSO:

Genetics: New Heat Tolerant Cow Developed

Hamilton, New Zealand-based Dairy Solutionz Ltd has led an expert genetics team to develop a new dairy cow breed conditioned to thrive in lower elevation tropical climates and achieve high milk production under heat stress. More>>

Fractals: Thousands More Business Cards Needed To Build Giant Sponge

New Zealand is taking part in a global event this weekend to build a Menger Sponge using 15 million business cards but local organisers say they are thousands of business cards short. More>>

Scoop Business: NZ Net Migration Rises To Annual Record In September

New Zealand’s annual net migration rose to a record in September, beating government forecasts, as the inflow was spurred by student arrivals from India and Kiwis returning home from Australia. More>>

ALSO:

Scoop Business: Fletcher To Close Its Christchurch Insulation Plant, Cut 29 Jobs

Fletcher Building, New Zealand’s largest listed company, will close its Christchurch insulation factory, as it consolidates its Tasman Insulations operations in a “highly competitive market”. More>>

ALSO:

Scoop Business: Novartis Adds Nine New Treatments Under Pharmac Deal

Novartis New Zealand, the local unit of the global pharmaceuticals firm, has added nine new treatments in a far-ranging agreement with government drug buying agency, Pharmac. More>>

ALSO:

Crown Accounts: English Wary On Tax Take, Could Threaten Surplus

Finance Minister Bill English is warning the tax take may come in below forecast in the current financial year, as figures released today confirm it was short by nearly $1 billion in the year to June 30 and English warned of the potential impact of slumping receipts from agricultural exports. More>>

ALSO:

Get More From Scoop

 
 
Standards New Zealand

Standards New Zealand

Mosh Social Media
 
 
 
 
 
 
 
 
Sci-Tech
Search Scoop  
 
 
Powered by Vodafone
NZ independent news